Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men

Atherosclerosis

Volumn 240, Issue 1, 2015, Pages 272-277

  Fizelova, Maria ^a   Miilunpohja, Manna ^b   Kangas, Antti J ^c   Soininen, Pasi ^a,c   Kuusisto, Johanna ^a,b   Ala Korpela, Mika ^a,c,d,e   Laakso, Markku ^a,b   Stančáková, Alena ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Apolipoproteins; Atherogenic indices; Hyperglycemia; Insulin resistance; Insulin secretion; Lipoproteins; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOA1 PROTEIN, HUMAN; APOB PROTEIN, HUMAN; APOLIPOPROTEIN B100; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; BLOOD; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FINLAND; GENETICS; INCIDENCE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE;

AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEIN B-100; BIOMARKERS; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FINLAND; HUMANS; INCIDENCE; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEX FACTORS;

EID: 84925428155     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.03.034     Document Type: Article

References (31)

1. Adiels M., Olofsson S.O., Taskinen M.R., Boren J. Diabetic dyslipidaemia. Curr. Opin. Lipidol. 2006, 17:238-246.
2. Taskinen M.R. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003, 46:733-749.
3. Adiels M., Olofsson S.O., Taskinen M.R., Boren J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1225-1236.
4. Laakso M., Barrett-Connor E. Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Arteriosclerosis 1989, 9:665-672.
5. Goldberg I.J. Clinical review 124. Diabetic dyslipidemia: causes and consequences. J.Clin. Endocrinol. Metab. 2001, 86:965-971.
6. Festa A., Williams K., Hanley A.J., Otvos J.D., Goff D.C., Wagenknecht L.E., Haffner S.M. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 2005, 111:3465-3472.
7. Mackey R.H., Mora S., Bertoni A.G., Wassel C.L., Carnethon M.R., Sibley C.T., Goff D.C. Lipoprotein particles and incident type 2 diabetes in the multi- ethinic study of atherosclerosis Advanced online publication. Diabetes Care 2015, 15 Jan, 10.2337/dc14-0645.
8. Mora S., Otvos J.D., Rosenson R.S., Pradhan A., Buring J.E., Ridker P.M. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes 2010, 59:1153-1160.
9. Austin M.A., Mykkanen L., Kuusisto J., Edwards K.L., Nelson C., Haffner S.M., Pyorala K., Laakso M. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation 1995, 92:1770-1778.
10. Fagot-Campagna A., Knowler W.C., Narayan K.M., Hanson R.L., Saaddine J., Howard B.V. HDL cholesterol subfractions and risk of developing type 2 diabetes among Pima Indians. Diabetes Care 1999, 22:271-274.
11. Abbasi A., Corpeleijn E., Gansevoort R.T., Gans R.O., Hillege H.L., Stolk R.P., Navis G., Bakker S.J., Dullaart R.P. Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study. J.Clin. Endocrinol. Metab. 2013, 98:E1352-E1359.
12. Fagot-Campagna A., Narayan K.M., Hanson R.L., Imperatore G., Howard B.V., Nelson R.G., Pettitt D.J., Knowler W.C. Plasma lipoproteins and incidence of non-insulin-dependent diabetes mellitus in Pima Indians: protective effect of HDL cholesterol in women. Atherosclerosis 1997, 128:113-119.
13. Onat A., Can G., Cicek G., Ayhan E., Dogan Y. Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: population-based cohort study. Clin. Biochem. 2010, 43:1381-1386.
14. Hwang Y.C., Ahn H.Y., Kim W.J., Park C.Y., Park S.W. Increased apoB/A-I ratio independently associated with Type 2 diabetes mellitus: cross-sectional study in a Korean population. Diabet. Med. 2012, 29:1165-1170.
15. Ley S.H., Harris S.B., Connelly P.W., Mamakeesick M., Gittelsohn J., Wolever T.M., Hegele R.A., Zinman B., Hanley A.J. Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population. Clin. Chem. 2010, 56:666-670.
16. Jian Z.H., Lung C.C., Ko P.C., Sun Y.H., Huang J.Y., Ho C.C., Ho C.Y., Chiang Y.C., Chen C.J., Liaw Y.P. The association between the apolipoprotein A1/high density lipoprotein -cholesterol and diabetes in Taiwan - a cross-sectional study. BMC Endocr. Disord. 2013, 13:42.
17. Stancakova A., Javorsky M., Kuulasmaa T., Haffner S.M., Kuusisto J., Laakso M. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 2009, 58:1212-1221.
18. Expert Committee on the D, Classification of Diabetes M Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl.1):S5-S20.
19. Soininen P., Kangas A.J., Wurtz P., Tukiainen T., Tynkkynen T., Laatikainen R., Jarvelin M.R., Kahonen M., Lehtimaki T., Viikari J., Raitakari O.T., Savolainen M.J., Ala-Korpela M. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst 2009, 134:1781-1785.
20. Inouye M., Kettunen J., Soininen P., Silander K., Ripatti S., Kumpula L.S., Hamalainen E., Jousilahti P., Kangas A.J., Mannisto S., Savolainen M.J., Jula A., Leiviska J., Palotie A., Salomaa V., Perola M., Ala-Korpela M., Peltonen L. Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol. Syst. Biol. 2010, 6:441.
21. Soininen P., Kangas A.J., Würtz P., Suna T., Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ. Cardiovasc. Genet. February 2015, [Epub ahead of print] http://dx.doi.org/10.1161/CIRCGENETICS.114.000216.
22. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
23. Wang J., Stancakova A., Soininen P., Kangas A.J., Paananen J., Kuusisto J., Ala-Korpela M., Laakso M. Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men. J.Intern. Med. 2012, 272:562-572.
24. Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.D., Patterson J.K. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?. JAMA 1990, 263:2893-2898.
25. Wilson P.W., Meigs J.B., Sullivan L., Fox C.S., Nathan D.M., D'Agostino R.B. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch. Intern. Med. 2007, 167:1068-1074.
26. Onat A., Hergenc G., Bulur S., Ugur M., Kucukdurmaz Z., Can G. The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks. Int. J. Cardiol. 2010, 142:72-79.
27. Dotevall A., Johansson S., Wilhelmsen L., Rosengren A. Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabet. Med. 2004, 21:615-622.
28. Hjellvik V., Sakshaug S., Strom H. Body mass index, triglycerides, glucose, and blood pressure as predictors of type 2 diabetes in a middle-aged Norwegian cohort of men and women. Clin. Epidemiol. 2012, 4:213-224.
29. Tirosh A., Shai I., Bitzur R., Kochba I., Tekes-Manova D., Israeli E., Shochat T., Rudich A. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care 2008, 31:2032-2037.
30. Krauss R.M., Siri P.W. Dyslipidemia in type 2 diabetes. Med. Clin. North Am. 2004, 88:897-909.
31. Laakso M., Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat. Rev. Endocrinol. 2014, 10:293-302.